🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/08/2006 | 37,77 | 38,41 | 37,74 | 37,93 | +0,25% | 1,77% | 10.208.673 |
| 21/08/2006 | 38,17 | 38,36 | 37,62 | 37,83 | +0,33% | 1,93% | 13.137.728 |
| 18/08/2006 | 36,83 | 38,00 | 36,59 | 37,71 | +1,78% | 3,81% | 22.871.657 |
| 17/08/2006 | 39,41 | 39,82 | 36,26 | 37,05 | -5,71% | 9,03% | 38.334.897 |
| 16/08/2006 | 39,36 | 39,52 | 39,09 | 39,29 | +0,56% | 1,09% | 7.193.262 |
| 15/08/2006 | 39,34 | 39,50 | 39,01 | 39,07 | +0,17% | 1,26% | 10.064.678 |
| 14/08/2006 | 38,98 | 39,41 | 38,85 | 39,01 | +0,69% | 1,44% | 7.051.258 |
| 11/08/2006 | 39,07 | 39,17 | 38,57 | 38,74 | -1,77% | 1,54% | 8.833.802 |
| 10/08/2006 | 39,31 | 39,53 | 38,99 | 39,44 | -0,31% | 1,38% | 7.004.937 |
| 09/08/2006 | 39,12 | 39,80 | 39,11 | 39,56 | +1,17% | 1,76% | 9.845.331 |
| 08/08/2006 | 39,13 | 39,39 | 38,84 | 39,10 | +0,34% | 1,41% | 8.638.769 |
| 07/08/2006 | 39,46 | 39,57 | 38,32 | 38,97 | -1,23% | 3,17% | 8.981.046 |
| 04/08/2006 | 39,73 | 39,87 | 39,09 | 39,46 | -0,58% | 1,95% | 8.086.892 |
| 03/08/2006 | 39,23 | 39,85 | 38,90 | 39,69 | +1,36% | 2,41% | 10.418.168 |
| 02/08/2006 | 38,93 | 39,21 | 38,81 | 39,15 | +0,51% | 1,03% | 10.736.760 |
| 01/08/2006 | 38,53 | 39,21 | 38,34 | 38,95 | +1,37% | 2,25% | 10.332.861 |
| 31/07/2006 | 39,23 | 39,23 | 38,32 | 38,43 | -2,07% | 2,31% | 12.825.634 |
| 28/07/2006 | 39,12 | 39,85 | 38,88 | 39,24 | +0,34% | 2,46% | 17.317.886 |
| 27/07/2006 | 38,43 | 39,18 | 38,22 | 39,10 | +1,99% | 2,51% | 21.308.774 |
| 26/07/2006 | 37,37 | 38,42 | 37,36 | 38,34 | +2,32% | 2,83% | 14.013.961 |
| 25/07/2006 | 37,48 | 37,68 | 37,19 | 37,47 | +0,82% | 1,32% | 12.344.182 |
| 24/07/2006 | 36,26 | 37,40 | 36,26 | 37,17 | +4,26% | 3,13% | 21.004.645 |
| 21/07/2006 | 35,68 | 35,85 | 35,49 | 35,65 | +0,16% | 1,02% | 9.677.861 |
| 20/07/2006 | 35,39 | 35,72 | 35,35 | 35,59 | -0,05% | 1,02% | 6.725.016 |
| 19/07/2006 | 35,16 | 35,91 | 34,88 | 35,61 | +1,72% | 2,93% | 15.421.634 |
| 18/07/2006 | 34,70 | 35,25 | 34,61 | 35,01 | +0,88% | 1,84% | 7.835.372 |
| 17/07/2006 | 34,49 | 34,83 | 34,25 | 34,70 | +0,61% | 1,69% | 7.234.658 |
| 14/07/2006 | 35,25 | 35,36 | 34,12 | 34,49 | -2,14% | 3,52% | 10.931.793 |
| 13/07/2006 | 34,83 | 35,35 | 33,40 | 35,25 | +0,65% | 5,62% | 21.902.047 |
| 12/07/2006 | 35,48 | 35,68 | 34,80 | 35,02 | -1,53% | 2,47% | 7.754.466 |